Overview

Obatoclax for Systemic Mastocytosis

Status:
Terminated

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if obatoclax mesylate can help to control systemic mastocytosis. The safety of this drug will also be tested.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Gemin X

Treatments:

Obatoclax